Immunological difference between botulinum toxin subtypes A1 and A2 using polyclonal antibody

被引：0
|
作者：
Torii, Y. [1 ]
Shinmura, M. [1 ]
Takahashi, M. [2 ]
Kohda, T. [3 ]
Kozaki, S. [3 ]
Nakahira, S. [1 ]
Ginnaga, A. [1 ]
机构：
[1] Chemoserotherapeut Res Inst, Kumamoto, Japan
[2] Natl Inst Infect Dis, Tokyo, Japan
[3] Osaka Prefecture Univ, Osaka, Japan
来源：
TOXICON | 2013年 / 68卷
关键词：
D O I：
10.1016/j.toxicon.2012.07.115
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：100 / 101
页数：2
相关论文
共 50 条
  • [1] Differences in immunological responses of polyclonal botulinum A1 and A2 antitoxin against A1 and A2 toxin
    Torii, Yasushi
    Shinmura, Miho
    Kohda, Tomoko
    Kozaki, Shunji
    Takahashi, Motohide
    Ginnaga, Akihiro
    TOXICON, 2013, 73 : 9 - 16
  • [2] Clinical differences between A1 and A2 botulinum toxin subtypes
    Kaji, Ryuji
    TOXICON, 2015, 107 : 85 - 88
  • [3] Comparison of efficacy and toxicity between botulinum toxin subtypes A1 and A2 in cynomolgus macaques
    Torii, Yasushi
    Sasaki, Mikio
    Shin, Min-Chul
    Akaike, Norio
    Kaji, Ryuji
    TOXICON, 2018, 153 : 114 - 119
  • [4] Comparison of Systemic Toxicity between Botulinum Toxin Subtypes A1 and A2 in Mice and Rats
    Torii, Yasushi
    Goto, Yoshitaka
    Nakahira, Shinji
    Kozaki, Shunji
    Kaji, Ryuji
    Ginnaga, Akihiro
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 116 (06) : 524 - 528
  • [5] Entry of Botulinum Neurotoxin Subtypes A1 and A2 into Neurons
    Kroken, Abby R.
    Blum, Faith C.
    Zuverink, Madison
    Barbieri, Joseph T.
    INFECTION AND IMMUNITY, 2017, 85 (01)
  • [6] Comparison of the immunogenicity of botulinum toxin type A and the efficacy of A1 and A2 neurotoxins in animals with A1 toxin antibodies
    Torii, Yasushi
    Goto, Yoshitaka
    Nakahira, Shinji
    Kozaki, Shunji
    Ginnaga, Akihiro
    TOXICON, 2014, 77 : 114 - 120
  • [7] Spinal central effects of peripherally applied botulinum neurotoxin A in comparison between its subtypes A1 and A2
    Koizumi, Hidetaka
    Goto, Satoshi
    Okita, Shinya
    Morigaki, Ryoma
    Akaike, Norio
    Torii, Yasushi
    Harakawa, Tetsuhiro
    Ginnaga, Akihiro
    Kaji, Ryuji
    FRONTIERS IN NEUROLOGY, 2014, 5
  • [8] Comparative study of spread of A1 and A2 subtypes of botulinum toxin preparations for blepharospasm: Proof-of-concept randomized controlled trial
    Kaji, R.
    Miyashiro, A.
    Kaji, S.
    Takeuchi, T.
    MOVEMENT DISORDERS, 2015, 30 : S510 - S510
  • [9] ANTIGENIC DIFFERENCE BETWEEN HUMAN SUBGROUPS A1 AND A2
    CUNNINGHAM, RK
    ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA SECTION B-MICROBIOLOGY AND IMMUNOLOGY, 1972, B 80 (01): : 162 - +
  • [10] Comparison of effects, safety, and immunogenicity of botulinum toxin subtypes Al and A2
    Torii, Yashushi
    Nakahira, Shinji
    Harakawa, Tetsuhiro
    Akaike, Norio
    Shin, Min-Chul
    Ginnaga, Akihiro
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2010, 60 : S34 - S34
12345